NRX Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: NRXP
Share price (10/8/26): $2.89
Market cap (10/8/26): $125 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Removal from listing

Prospectus supplement for primary offering

Prospectus supplement

Ownership Filter

Anson Funds Management LP

Casper Joseph Michael

Casper Joseph Michael

Javitt Jonathan C

News Filter

Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in Conjunction With NRX-101 for Treatment of Resistant Depression

Reports Update From the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-Free Ketamine

Material Disclosure, Financial Statements or Exhibits

Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to Be Held on Monday, August 17th at 4:30pm ET

Material Disclosure

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission